Active Recombinant Human PILRA, His-tagged

• Cat.No.: PILRA-513H
• Product Overview: Recombinant Human PILRA (Accession # CAC01613) Gln20-Thr196, fused with a C-terminal 6-His tag, was produced in Mouse myeloma cell line, NS0-derived.

Specification

• Source: Mammalian cells
• Species: Human
• Tag: His
• Predicted N Terminal: Gln20 predicted: No results obtained, sequencing might be blockedThr25 (Minor)
• Form: Lyophilized from a 0.2 µm filtered solution in PBS and EDTA.
• Bio-activity: Measured by its binding ability in a functional ELISA.When recombinant human PANP Fc Chimera is immobilized at 5 µg/mL (100 µL/well), the concentration of Recombinant Human PILR-alpha that produces 50% optimal binding response is approximately 0.4-2 µg/mL.
• Molecular Mass: Recombinant Human PILRA, His-tagged has a calculated MW of 20.9 kDa. In SDS-PAGE migrates as 33-40 kDa, reducing conditions.
• Purity: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Storage: Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).
• Protein length: 20-196 a.a.

Gene Information

• Gene Name: PILRA paired immunoglobin-like type 2 receptor alpha [ Homo sapiens ]
• Official Symbol: PILRA
• Synonyms: PILRA; paired immunoglobin-like type 2 receptor alpha; paired immunoglobulin-like type 2 receptor alpha; FDF03; cell surface receptor FDF03; inhibitory receptor PILR-alpha
• Gene ID: 29992
• mRNA Refseq: NM_013439
• Protein Refseq: NP_038467
• MIM: 605341
• UniProt ID: Q9UKJ1
• Chromosome Location: 7q22.1